1,967 top medical experts on Pulmonary Embolism across 60 countries and 45 U.S. states, including 1,885 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Pulmonary Embolism: Blocking of the pulmonary artery or one of its branches by an embolus.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Lung Diseases (3,785), Embolism (2,342) and Narrower Categories: Pulmonary Infarction (326).
  4. Clinical Trials ClinicalTrials.gov : at least 552 including 16 Active, 279 Completed, 88 Recruiting
  5. Synonyms: Pulmonary Thromboembolism,  Pulmonary Thromboembolism


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Lang, Irene Marthe     Google Publications
    Department of Cardiology, Pulmonary Hypertension Unit, Medical University of Vienna, Vienna, Austria.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports 
    Subjects: Hypertension, Pulmonary; Pulmonary Artery; Anticoagulants; Thrombolytic Therapy; Endarterectomy
    Categories: Diagnosis; Therapy; Complications; Therapeutic Use; Etiology; Epidemiology
    2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). (2020)
    2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. (2014)

  2. Torbicki, Adam     Google Publications
    Dept of Pulmonary Circulation, Thrombo-embolic Diseases and Cardiology, Center of Postgraduate Medical Education, ECZ-Otwock, Otwock, Poland.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Subjects: Hypertension, Pulmonary; Angioplasty, Balloon; Pulmonary Artery; Anticoagulants; Cardiology
    Categories: Therapy; Physiopathology; Complications; Therapeutic Use; Epidemiology; Diagnosis
    2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). (2020)
    2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. (2014)

  3. Righini, Marc     ClinicalTrials.gov Google Publications
    Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Subjects: Venous Thromboembolism; Fibrin Fibrinogen Degradation Products; Anticoagulants; Venous Thrombosis; Natriuretic Peptide, Brain
    Categories: Diagnosis; Blood; Epidemiology; Methods; Diagnostic Imaging; Drug Therapy
    2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). (2020)
    2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). (2019)

  4. Ohana, Mickaël     Google Publications
    Radiology Department, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
    Physician  Highly Cited  Review 
    Subjects: COVID-19; Venous Thrombosis; Anticoagulants; Betacoronavirus; Coronavirus Infections
    Categories: Physiopathology; Diagnostic Imaging; Complications; Methods; Diagnosis; Metabolism
    High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. (2020)
    Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis. (2021)

  5. Goldhaber, Samuel Z     ClinicalTrials.gov Google Publications
    Division of Cardiovascular Medicine G.P., S.Z.G., Brigham and Womens Hospital, Harvard Medical School, Boston. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Subjects: Venous Thromboembolism; Anticoagulants; Fibrinolytic Agents; Venous Thrombosis; Thrombolytic Therapy
    Categories: Therapeutic Use; Drug Therapy; Prevention & Control; Diagnostic Imaging; Methods; Administration & Dosage
    Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. (2011)
    Fibrinolysis for patients with intermediate-risk pulmonary embolism. (2014)

  6. Tapson, Victor F   Pulmonary Disease   ClinicalTrials.gov Google Publications
    Pulmonary and Critical Care Division, Cedars-Sinai Medical Center, Los Angeles, CA.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Relevant US NIH Grant Funding: $4,226,371 over the last 5 years
    Medicare MIPS (Merit-based Incentive Payment System) rating: 69/100
    Disclosed payments in 2021 from 36 biomedical companies, totalling $104,543.33, including $50,375 from  Janssen Research & Development, LLC
    Subjects: Fibrinolytic Agents; Thrombolytic Therapy; Venous Thromboembolism; Anticoagulants; Catheterization
    Categories: Therapy; Methods; Diagnosis; Administration & Dosage; Therapeutic Use; Drug Therapy
    Chronic thromboembolic pulmonary hypertension. (2019)
    A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE Study. (2019)

  7. Helms, Julie    Google Publications
    Hôpitaux Universitaires de Strasbourg, Service de Médecine Intensive Réanimation, Nouvel Hôpital Civil, 1, place de lHôpital, 67091, Strasbourg cedex, France.
    Physician 
    Subjects: Coronavirus Infections; Pneumonia, Viral; Anticoagulants; Betacoronavirus; Fibrin Fibrinogen Degradation Products
    Categories: Physiopathology; Metabolism; Pathogenicity; Therapeutic Use
    High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. (2020)
    Prothrombotic phenotype in COVID-19 severe patients. (2020)

  8. Meziani, Ferhat     Google Publications
    Hôpitaux Universitaires de Strasbourg, Service de Médecine Intensive Réanimation, Nouvel Hôpital Civil, 1, place de lHôpital, 67091, Strasbourg cedex, France. .
    Physician 
    Subjects: Coronavirus Infections; Pneumonia, Viral; Anticoagulants; Betacoronavirus; Fibrin Fibrinogen Degradation Products
    Categories: Physiopathology; Metabolism; Pathogenicity; Therapeutic Use
    High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. (2020)
    Prothrombotic phenotype in COVID-19 severe patients. (2020)

  9. Jaff, Michael R   Internal Medicine  Google Publications
    Chief Medical Officer, Vice President, Clinical Affairs, Technology & Innovation, Peripheral Interventions, Boston Scientific, Maple Grove, Minnesota.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $5,372.3, including $5,250 from  Silk Road Medical, Inc.
    Subjects: Anticoagulants; Venous Thrombosis; Fibrinolytic Agents; Patient Care Team; Thrombolytic Therapy
    Categories: Therapy; Methods; Drug Therapy; Organization & Administration; Therapeutic Use; Administration & Dosage
    Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. (2011)
    A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. (2015)

  10. Madani, Michael M   Thoracic Surgery (Cardiothoracic Vascular Surgery)   Google Publications
    Department of Cardiovascular and Thoracic Surgery, University of California San Diego, La Jolla, California. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $1,637.39, including $1,564.75 from  Bayer HealthCare Pharmaceuticals Inc.
    Subjects: Hypertension, Pulmonary; Endarterectomy; Pulmonary Artery; Thrombectomy; Angioplasty, Balloon
    Categories: Surgery; Diagnostic Imaging; Methods; Therapy; Diagnosis; Physiopathology
    Chronic thromboembolic pulmonary hypertension. (2019)
    ERS statement on chronic thromboembolic pulmonary hypertension. (2021)

  11. Kabrhel, Christopher   Emergency Medicine   ClinicalTrials.gov Google Publications
    Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Relevant US NIH Grant Funding: $644,066 over the last 5 years
    Medical school: Johns Hopkins University School of Medicine (MD, 1999)
    Medicare Accepted
    Subjects: Emergency Service, Hospital; Patient Care Team; Thrombolytic Therapy; Anticoagulants; Venous Thromboembolism
    Categories: Therapy; Methods; Diagnosis; Statistics & Numerical Data; Drug Therapy; Administration & Dosage
    Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association. (2019)
    Cardiovascular Risk Factors Associated With Venous Thromboembolism. (2019)

  12. Kline, Jeffrey Allen   Emergency Medicine   ClinicalTrials.gov Google Publications
    Department of Emergency Medicine, Wayne State School of Medicine, Detroit, Michigan, United States of America.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Review 
    Relevant US NIH Grant Funding: $5,124,560 over the last 5 years
    Medical school: Other (MD, 1990)
    Medicare Accepted
    Disclosed payments in 2021 from 3 biomedical companies, totalling $1,391.71, including $1,250 from  Diagnostica Stago, Inc
    Subjects: Emergency Service, Hospital; Anticoagulants; Venous Thromboembolism; Fibrin Fibrinogen Degradation Products; Venous Thrombosis
    Categories: Diagnosis; Therapeutic Use; Drug Therapy; Epidemiology; Diagnostic Imaging; Etiology
    Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. (2011)
    Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). (2011)

  13. Davidson, Bruce L   Pulmonary Disease  Google Publications
    University of Washington School of Medicine, Seattle, WA, USA. Top Hospital
    Physician  Highly Cited  Clinical Trial 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 84.8/100
    Subjects: Anticoagulants; Hemorrhage; Morpholines; Thiophenes; Enoxaparin
    Categories: Therapeutic Use; Administration & Dosage; Drug Therapy; Methods; Antagonists & Inhibitors; Chemically Induced
    Oral rivaroxaban for symptomatic venous thromboembolism. (2010)
    Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. (2012)

  14. Kluge, Stefan    Google Publications
    University Medical Center Hamburg-Eppendorf, Hamburg, Germany D.W., J.S., M.L., S.S., C.E., A.H., F.H., H.M., I.K., A.S.S., C.B., G.D., A.N., D.F., S.P., S.S., C.B., M.M.A., M.A., K.P., S.K..
    Physician 
    Subjects: Anticoagulants; Autopsy; Chest Pain; Coronavirus Infections; Echocardiography
    Categories: Mortality; Methods; Diagnosis; Therapeutic Use; Therapy; Statistics & Numerical Data
    Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. (2020)

  15. Schellong, Sebastian M    Google Publications
    Department of Internal Medicine 2, Municipal Hospital Dresden, Dresden, Germany.
    Physician  Highly Cited  Clinical Trial 
    Subjects: Anticoagulants; Venous Thrombosis; Venous Thromboembolism; Dabigatran; Factor Xa Inhibitors
    Categories: Therapeutic Use; Drug Therapy; Epidemiology; Diagnosis; Prevention & Control; Administration & Dosage
    Oral rivaroxaban for symptomatic venous thromboembolism. (2010)
    Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. (2012)

  16. Piazza, Gregory   Cardiovascular Disease   ClinicalTrials.gov Google Publications
    Division of Cardiovascular Medicine G.P., S.Z.G., Brigham and Womens Hospital, Harvard Medical School, Boston. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports 
    Disclosed payments in 2021 from 18 biomedical companies, totalling $49,132.1, including $21,125 from  Janssen Research & Development, LLC
    Subjects: Fibrinolytic Agents; Thrombolytic Therapy; Anticoagulants; Venous Thromboembolism; Embolectomy
    Categories: Therapy; Methods; Administration & Dosage; Diagnostic Imaging; Drug Therapy; Therapeutic Use
    A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. (2015)
    A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial. (2018)

  17. Rosenfield, Kenneth   Cardiovascular Disease  ClinicalTrials.gov Google Publications
    Massachusetts General Hospital, Harvard Medical School, Boston, MA. Top Hospital
    Physician  Highly Published  Guideline  Clinical Trial  Case Reports 
    Medical school: University of Massachusetts Medical School (MD, 1982)
    Medicare Accepted
    Disclosed payments in 2021 from 30 biomedical companies, totalling $337,995.93, including $241,020 from  Imperative Care, Inc
    Subjects: Patient Care Team; Thrombectomy; Thrombolytic Therapy; Anticoagulants; Embolectomy
    Categories: Therapy; Methods; Organization & Administration; Statistics & Numerical Data; Therapeutic Use; Diagnostic Imaging
    A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE Study. (2019)
    Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium. (2019)

  18. Yusen, Roger D   Pulmonary Disease  Google Publications
    Divisions of Pulmonary and Critical Care Medicine and General Medical Sciences, Washington University School of Medicine in St Louis, St Louis, Missouri.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports  Review 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 84/100
    Disclosed payments from biomedical company (Gyrus ACMI, Inc.) in 2021 for $1,284.8
    Subjects: Venous Thrombosis; Anticoagulants; Multidetector Computed Tomography; Thrombosis; Venous Thromboembolism
    Categories: Diagnosis; Complications; Methods; Diagnostic Imaging; Drug Therapy; Mortality
    Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. (2010)
    Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. (2014)

  19. Weinberg, Ido   Internal Medicine   Google Publications
    Division of Cardiology, Massachusetts General Hospital, Boston, MA. Top Hospital
    Physician  Highly Published  Guideline  Case Reports 
    Disclosed payments in 2021 from 3 biomedical companies, totalling $8,803.11, including $8,803.11 from  Penumbra, Inc.
    Subjects: Thrombolytic Therapy; Anticoagulants; Fibrinolytic Agents; Patient Care Team; Vena Cava Filters
    Categories: Therapy; Methods; Organization & Administration; Drug Therapy; Therapeutic Use; Diagnostic Imaging
    Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. (2014)
    Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association. (2019)

  20. Giri, Jay S   Interventional Cardiology   Google Publications
    Hospital of the University of Pennsylvania, Philadelphia, PA. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 78/100
    Disclosed payments in 2021 from 26 biomedical companies, totalling $3,001.2, including $1,611 from  AstraZeneca Pharmaceuticals LP
    Subjects: Thrombolytic Therapy; Fibrinolytic Agents; Anticoagulants; Patient Care Team; Embolectomy
    Categories: Methods; Therapy; Drug Therapy; Adverse Effects; Organization & Administration; Therapeutic Use
    Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. (2014)
    Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association. (2019)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);